| Tag | Content |
|---|
EnhancerAtlas ID | HS091-11071 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr12:120714270-120716300 |
Target genes | | Number: 13 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr12:120715201-120715216 | TGAACTCCTGACCTC | - | 6.22 | | SOX10 | MA0442.2 | chr12:120714297-120714308 | AAAACAAAGAA | + | 6.62 | | ZNF263 | MA0528.1 | chr12:120714370-120714391 | TTTCCACCTTCATCCTCCTCT | - | 6.09 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_55760 | chr12:120714165-120714713 | u87 | | SE_68119 | chr12:120694476-120731991 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I120276 | chr12 | 120714166 | 120714713 |
|
Enhancer Sequence | AAAAAAAAAA AAAAAAAAAA GTTAAAGAAA ACAAAGAATT ATAAGGTCAA AAAGGATCTC 60
AAGAGATTCT TCAACCTTTT CTCAGGTGAA GGGGGCTGGA TTTCCACCTT CATCCTCCTC 120
TCTATCACCT AAGGACCCCA TATGTTGACC GGGTGTCCAC CTGGAAGTCA TCCTCTGTTC 180
CTCCCCGTCC TCGCTTTCCA CACCCAGTTC TGCCTGTCCA TCTGCAAAGT GTAGCCCAAT 240
TCCCACCCCC ACCCCCTCAT TTTCACCTCT GCAATTATAT CTCTAGGTGC AGCCACGCAC 300
TACCCTCTCT TGCCTGGGAT TACTGCATGA ACCTCCAAAC TGGACCTCTA TTGTCAATTT 360
TCTACCCAGA AGCCAATAAG CCAATGTTAT CTTTTTAAAA AAATTTTTTT GAGATGGAGT 420
CTTGCTGTAT CACCCAGGCT GGAATGCAAT GGCGCAATCT TGACTCACTG CAACCATCAC 480
CTCCCAGGTT CAAGCCATTC TCCTGCTTCA GCCTCCCAAG TAGCTGGGAC TACAGGCACG 540
CTATCACGCC CGGCTAATTT TTCTTATTTT TAGTAGAGAC AGGGTTTTGC CATGTTGCCC 600
AGGCTGGTTC TGAACTCCTA ACCTTGGGTG ATCCACCCCC CTCGGCCTCC CAAAGTGCTG 660
GGATTACAGG CGTGAGCCAC GGCACCAGCC TAATGTTATT TTATTTTATT TTATTTATTT 720
ATTTATTTCG AGACGGAGTC TCACTCTGTC GTCCAGGCTG GAGTGCAGTG GTATGATCTC 780
GGCTCACTGC AACCTCCGCC TCCCAGGTTC AAGTGATTCT CCTGCCTCAG CCTACTGGGT 840
AGCTGTGATT ACAGTCACAC GACACAACAC CTGGATAATT TTTTGTATTT TTAGTAGAGA 900
CAGTGTCTCA CCATGTTGGC CAGTCTGGTC TTGAACTCCT GACCTCTGGA GATCCGCCCC 960
CCTCGGCCTC CCAAAGTGCT GGGATTACAG GCGTGAGTAC CCGGCAATGT TATGGTTTTT 1020
TTGTTTTTTT TTTTTAGTAT TTATTGATCA TTCTTGGGTG TTTCCCAGAG AGGGGGAAGT 1080
GGCAGGGTCA TAGGATAATA GTGGAGAGAA GGTCAGCAGA TAAACACGTG AACAAAGGTC 1140
TCTGGTTTTC CTAGGCAGAG GTCCCTGCGG CCTTCGGCCT TCAGCAGTGT TTGTGTCCCT 1200
GGGTACTTGA GATTAGGGAG TGGTGATGAC TCTTAAGGAG CATGCTGCCT TCAAGCATCT 1260
GTTTAACAAA GCACATCTTG CACCGCCCTT AATGCATTTA ACCCTGAGTT GACACAGCAC 1320
ATGTTTCAGA GAGTACGGGG TTGGGGGTAA GGTTATAGAT TAACAGCATC CCAAGGCAGA 1380
AGAATTTTTC TTAGTACAGA ACAAAATGGT GTCTCCTATG TCTGCTTCTT TCTACACAGA 1440
CACAGTAACA ATCTGATCTC TCTTTCTTTT CCCCACATTT CCCCCTTTTC TTTTCGACAA 1500
AACCGCCATC GTCATCATGG CCCTTTCTCG ATGGTCGCTG TCTCTTCGGA GCTGTTGGGT 1560
ACACTTCCCA GGCGGGGCGG CCTGGCAGAG GCGCTCCTCA CCTCCCAGAA GGGGTGGTGG 1620
CTGGGCAGAG GCGCCCCTCA CATCCCAGAC GATGGGCAGC CGGGCAGAGG CGCCCCCCAC 1680
CTCCCTGATG GGGCAGCCGG GCAGAAACGC CCCCCACCTC CCAGACGGGG TGTCCGGGCA 1740
GAGGCGCCCC CCACCTCCCA GATGAAGGGC GGCCAGGCAG AGGTGCTCCC CACCTCCCAG 1800
ACGGGGGAGC CGGGCAGAGA CGCCCCTCAC CTCCCAGACG GGGTGGCTGG GCAGAGGCGC 1860
CCACTTCACA GACGGGGCGG CCGGGTAGAG GCACTCCTCC CAGATGGGGT GGCGGCCGGG 1920
CAGAGGTGCT CCTCACATCC CAGACAGGGT GGCGGCCAGG CAGAGGCGCT CCTCACCTCC 1980
CAGACGGGGT GGTGGCCGGG CAGAAGCGCT CCTCACCTCC CAGACGGGGT 2030
|
